Table 3. Predictors of SVR using univariate and multivariate logistic regression analysis.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
OR (95%CI) | P | OR (95%CI) | P | |
RVR | 5.32 (2.65–10.69) | <0.0001 | ||
AFP | 0.91 (0.86–0.96) | 0.001 | 0.931(0.87–0.98) | 0.016* |
PLT | 1.007 (1.002–1.012) | 0.009 | 1.003(0.997–1.009) | 0.355 |
IL28BCC (vs CT/TT) | 10.86 (5.37–21.92) | <0.0001 | 12.592 (5.65–28.03) | <0.001* |
PD-1 (GA+AA) vs GG | 1.97 (1.09–3.55) | 0.023 | 1.49 (.71–3.11) | 0.281 |
CTAL-4 (GG+AG) vs AA | 1.94 (1.1–3.34) | 0.022 | 2.07 (1.01–4.24) | 0.045* |
>1 odds ratio indicated that this factor was associated with an SVR to the treatment.
*Denotes p-values below the level of 0.05 which are considered significant